Talaris Therapeutics Stock Forecast for 2023 - 2025 - 2030
Updated on 05/07/2024
Talaris Therapeutics Stock Forecast and Price Target
Talaris Therapeutics's stock price reaches the average target of $3.05 by 2025 as expected recently by notable experts, there would be a potential upside of approximately 15.09% from the last closing price in October, 2023. This possible increase is based on a high estimate of $3.42 and a low estimate of $2.72.
15.09% Upside
Talaris Therapeutics Fair Value Forecast for 2023 - 2025 - 2030
In the last two years, Talaris Therapeutics's Price has seen an increase, rising from $0.00 to $0.00. This represents a growth of 100.00%. Analysts predict that Talaris Therapeutics's Fair Value will increase in the upcoming year, reaching $2.84. This would represent an increase of 100.00%. Over the next seven years, experts predict that Talaris Therapeutics's Fair Value will grow at a rate of 100.00%.
.jpg)
Talaris Therapeutics EBITDA Forecast for 2023 - 2025 - 2030
Talaris Therapeutics's EBITDA has grown in the last two years, jumping from $-22.24M to $-75.09M – an increase of 237.63%. In the following year, the 0 analysts surveyed believe that Talaris Therapeutics's EBITDA will decrease by 42.57%, reaching $-43.13M. According to professionals, by 2030, Talaris Therapeutics's EBITDA will have decreased by 32.00%, falling down to $-51.06M.
Talaris Therapeutics EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Talaris Therapeutics's EBIT has increased by 237.21%, going from $-22.68M to $-76.48M. The next year, 0 experts forecast that Talaris Therapeutics's EBIT will decrease by 42.67%, reaching $-43.84M. In 2030, professionals predict that Talaris Therapeutics's EBIT will decrease by 32.05%, reaching $-51.97M.
Talaris Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last two years, Talaris Therapeutics's EPS has seen an increase, rising from $-16.40 to $0.00. This represents a growth of 100.00%. Analysts predict that Talaris Therapeutics's EPS will increase in the upcoming year, reaching $0.00. This would represent an increase of 100.00%. Over the next seven years, experts predict that Talaris Therapeutics's EPS will grow at a rate of 100.00%.
.jpg)